SEC Comment Letter 0000000000-25-003257 to ASSEMBLY BIOSCIENCES, INC. (ASMB)
ASSEMBLY BIOSCIENCES, INC.
Date: March 26, 2025 · CIK: 0001426800 · Accession: 0000000000-25-003257
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-285970
Letter
Re: Assembly Biosciences, Inc. Registration Statement on Form S-3 Filed March 20, 2025 File No. 333-285970 Dear Jason A. Okazaki:
March 26, 2025
Jason A. Okazaki Chief Executive Officer and President Assembly Biosciences, Inc. Two Tower Place, 7th Floor South San Francisco, California 94080
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Chris Edwards at 202-551-6761 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: P. Michelle Gasaway, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> March 26, 2025 Jason A. Okazaki Chief Executive Officer and President Assembly Biosciences, Inc. Two Tower Place, 7th Floor South San Francisco, California 94080 Re: Assembly Biosciences, Inc. Registration Statement on Form S-3 Filed March 20, 2025 File No. 333-285970 Dear Jason A. Okazaki: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at 202-551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: P. Michelle Gasaway, Esq. </TEXT> </DOCUMENT>